Tag:
Nevada
Latest Headlines
Latest Headlines
Third jury rules against Teva, Baxter in hep C suit
A third Nevada jury has ruled against Teva Pharmaceuticals ( $TEVA) and Baxter International ( $BAX ). The panel ordered the two companies to pay $14 million for selling large vials of propofol, an
Jury levies $20M verdict against Teva in propofol case
Teva Pharmaceutical Industries ( $TEVA ) failed to persuade a Nevada jury its propofol drug wasn't responsible for a 2008 hepatitis C outbreak. The panel found Teva liable in the case, along with
